Reale, A., Gatta, A., Shaik, A. K. B., Shallak, M., Chiaravalli, A. M., Cerati, M., . . . Forlani, G. (2024). An oncolytic HSV-1 vector induces a therapeutic adaptive immune response against glioblastoma. Journal of Translational Medicine, 22(1), 1. https://doi.org/10.1186/s12967-024-05650-5
Chicago Style (17th ed.) CitationReale, Alberto, et al. "An Oncolytic HSV-1 Vector Induces a Therapeutic Adaptive Immune Response Against Glioblastoma." Journal of Translational Medicine 22, no. 1 (2024): 1. https://doi.org/10.1186/s12967-024-05650-5.
MLA (9th ed.) CitationReale, Alberto, et al. "An Oncolytic HSV-1 Vector Induces a Therapeutic Adaptive Immune Response Against Glioblastoma." Journal of Translational Medicine, vol. 22, no. 1, 2024, p. 1, https://doi.org/10.1186/s12967-024-05650-5.